Design of Ultrasound-Driven Charge Interference Therapy for Wound Infection

Area of Science:

• Nanomedicine
• Antimicrobial Therapy
• Biomaterials

Background:

• Wound infections caused by pathogenic bacteria pose a significant public health challenge.
• Current treatments often face complications and suboptimal therapeutic outcomes.
• Need for innovative strategies to combat antibiotic-resistant bacteria in wound infections.

Purpose of the Study:

• To develop novel antibacterial nanoparticles for treating wound infections.
• To investigate the mechanism of action of these nanoparticles, including charge interference and reactive oxygen species generation.
• To evaluate the efficacy of ultrasound-combined therapy against bacterial pathogens and biofilms.

Main Methods:

• Synthesis and characterization of PGTP nanoparticles (guanidine derivatives coordinated with a porphyrin-based sonosensitizer).
• Assessment of antibacterial activity against Gram-negative and Gram-positive bacteria.
• Evaluation of biofilm disruption and pathogen elimination under ultrasound stimulation.
• RNA-sequencing (RNA-seq) analysis to elucidate the molecular mechanisms of action.

Main Results:

• PGTP nanoparticles exhibit strong positive charge, effectively disrupting bacterial biosynthesis via charge interference.
• Ultrasound stimulation of PGTP nanoparticles generates reactive oxygen species, leading to biofilm disruption and pathogen elimination.
• RNA-seq data reveal that PGTP nanoparticles and ultrasound impair bacterial metabolism by interfering with amino acid synthesis and transcription.

Conclusions:

• PGTP nanoparticles represent a promising new class of antibacterial agents for wound infections.
• Ultrasound-driven charge-interfering therapy using PGTP nanoparticles offers an effective strategy against bacterial pathogens and biofilms.
• This approach provides a novel mechanism for wound healing by targeting bacterial metabolism.